Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP hydrolysis activity	DNAH3 ABCA1 ABCA2 VWA8 RTEL1 MYO19 DNAH7 ABCA9 ABCA8 ABCB1 ATP6V1H ATP8A1 ABCB11 DNAH5 DNAH8	3.13e-07	441	135	15	GO:0016887
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCA1 ABCA2 ABCA9 ABCA8 ABCB1 ATP6V1H ATP8A1 ABCB11	7.59e-07	109	135	8	GO:0042626
GeneOntologyMolecularFunction	ATP-dependent activity	DNAH3 ABCA1 ABCA2 VWA8 RTEL1 MYO19 DNAH7 DICER1 ABCA9 ABCA8 ABCB1 ATP6V1H ATP8A1 ABCB11 DNAH5 DNAH8 HELLS	8.76e-07	614	135	17	GO:0140657
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCA1 ABCA2 ABCA9 ABCA8 ABCB1 ABCB11	9.41e-07	49	135	6	GO:0140359
GeneOntologyMolecularFunction	sphingolipid floppase activity	ABCA1 ABCA2 ABCB1	1.20e-06	4	135	3	GO:0046623
GeneOntologyMolecularFunction	floppase activity	ABCA1 ABCA2 ABCB1 ATP8A1	3.41e-06	16	135	4	GO:0140328
GeneOntologyMolecularFunction	pyrophosphatase activity	DNAH3 ABCA1 ABCA2 VWA8 RTEL1 ENPP2 MYO19 BMS1 RGS11 DNAH7 ABCA9 ABCA8 ABCB1 ATP6V1H ATP8A1 ABCB11 DNAH5 DNAH8 RHOF	3.76e-06	839	135	19	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	DNAH3 ABCA1 ABCA2 VWA8 RTEL1 ENPP2 MYO19 BMS1 RGS11 DNAH7 ABCA9 ABCA8 ABCB1 ATP6V1H ATP8A1 ABCB11 DNAH5 DNAH8 RHOF	3.83e-06	840	135	19	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	DNAH3 ABCA1 ABCA2 VWA8 RTEL1 ENPP2 MYO19 BMS1 RGS11 DNAH7 ABCA9 ABCA8 ABCB1 ATP6V1H ATP8A1 ABCB11 DNAH5 DNAH8 RHOF	3.83e-06	840	135	19	GO:0016818
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	DNAH3 ABCA1 ABCA2 VWA8 RTEL1 MYO19 BMS1 RGS11 DNAH7 ABCA9 ABCA8 ABCB1 ATP6V1H ATP8A1 ABCB11 DNAH5 DNAH8 RHOF	4.91e-06	775	135	18	GO:0017111
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH3 DNAH7 DNAH5 DNAH8	5.68e-06	18	135	4	GO:0008569
GeneOntologyMolecularFunction	primary active transmembrane transporter activity	ABCA1 ABCA2 ABCA9 ABCA8 ABCB1 ATP6V1H ATP8A1 ABCB11	2.88e-05	178	135	8	GO:0015399
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH3 DNAH7 DNAH5 DNAH8	3.61e-05	28	135	4	GO:0051959
GeneOntologyMolecularFunction	ATPase-coupled intramembrane lipid transporter activity	ABCA1 ABCA2 ABCB1 ATP8A1	3.61e-05	28	135	4	GO:0140326
GeneOntologyMolecularFunction	lipid transporter activity	ABCA1 ABCA2 ABCA9 ABCA8 ABCB1 ATP8A1 ABCB11 SLC5A8	5.71e-05	196	135	8	GO:0005319
GeneOntologyMolecularFunction	active transmembrane transporter activity	ABCA1 SLC29A3 ABCA2 ABCA9 ABCA8 ABCB1 ATP6V1H ATP8A1 SLC17A7 ABCB11 SLC5A8 SLC17A6	9.77e-05	477	135	12	GO:0022804
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH3 DNAH7 DNAH5 DNAH8	1.11e-04	37	135	4	GO:0045505
GeneOntologyMolecularFunction	ABC-type xenobiotic transporter activity	ABCA8 ABCB1 ABCB11	1.30e-04	15	135	3	GO:0008559
GeneOntologyMolecularFunction	ceramide floppase activity	ABCA2 ABCB1	1.36e-04	3	135	2	GO:0099038
GeneOntologyMolecularFunction	L-glutamate uniporter activity	SLC17A7 SLC17A6	1.36e-04	3	135	2	GO:0140788
GeneOntologyMolecularFunction	sphingolipid transporter activity	ABCA1 ABCA2 ABCB1	3.17e-04	20	135	3	GO:0046624
GeneOntologyMolecularFunction	neurotransmitter transmembrane transporter activity	SLC29A3 SLC17A7 SLC17A6	3.68e-04	21	135	3	GO:0005326
GeneOntologyMolecularFunction	intramembrane lipid transporter activity	ABCA1 ABCA2 ABCB1 ATP8A1	3.90e-04	51	135	4	GO:0140303
GeneOntologyMolecularFunction	membrane potential driven uniporter activity	SLC17A7 SLC17A6	4.48e-04	5	135	2	GO:0022810
GeneOntologyMolecularFunction	G protein-coupled opioid receptor activity	OPRD1 OPRK1	9.32e-04	7	135	2	GO:0004985
GeneOntologyMolecularFunction	phosphatidylcholine floppase activity	ABCA1 ABCB1	1.24e-03	8	135	2	GO:0090554
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH3 MYO19 DNAH7 DNAH5 DNAH8	1.25e-03	118	135	5	GO:0003774
GeneOntologyMolecularFunction	microtubule motor activity	DNAH3 DNAH7 DNAH5 DNAH8	1.30e-03	70	135	4	GO:0003777
GeneOntologyMolecularFunction	xenobiotic transmembrane transporter activity	ABCA8 ABCB1 ABCB11	1.55e-03	34	135	3	GO:0042910
GeneOntologyMolecularFunction	phosphatidylserine floppase activity	ABCA1 ATP8A1	1.58e-03	9	135	2	GO:0090556
GeneOntologyMolecularFunction	receptor serine/threonine kinase binding	OPRD1 OPRK1 PYCARD	1.69e-03	35	135	3	GO:0033612
GeneOntologyMolecularFunction	uniporter activity	SLC17A7 SLC17A6	1.97e-03	10	135	2	GO:0015292
GeneOntologyMolecularFunction	transmembrane transporter activity	CHRNA6 ABCA1 SLC29A3 ABCA2 PIEZO1 SLC19A2 ABCA9 ABCA8 ABCB1 ATP6V1H ATP8A1 SCN1A SLC17A7 ABCB11 KCNS1 SLC5A8 SLC17A6	2.55e-03	1180	135	17	GO:0022857
GeneOntologyMolecularFunction	myosin binding	NPHS1 MYO19 PYCARD USH2A	2.65e-03	85	135	4	GO:0017022
GeneOntologyMolecularFunction	sodium:phosphate symporter activity	SLC17A7 SLC17A6	2.86e-03	12	135	2	GO:0005436
GeneOntologyMolecularFunction	carboxylic acid transmembrane transporter activity	SLC19A2 ABCB1 SLC17A7 ABCB11 SLC5A8 SLC17A6	2.87e-03	207	135	6	GO:0046943
GeneOntologyMolecularFunction	organic acid transmembrane transporter activity	SLC19A2 ABCB1 SLC17A7 ABCB11 SLC5A8 SLC17A6	2.94e-03	208	135	6	GO:0005342
GeneOntologyBiologicalProcess	sphingolipid translocation	ABCA1 ABCA2 ABCB1	2.84e-06	5	137	3	GO:0099039
GeneOntologyCellularComponent	axonemal dynein complex	DNAH3 DNAH7 DNAH5 DNAH8	2.12e-05	25	139	4	GO:0005858
GeneOntologyCellularComponent	exocytic vesicle membrane	DMXL2 DYSF OPRD1 OPRK1 ATP6V1H ATP8A1 SLC17A7 SLC17A6	2.68e-05	179	139	8	GO:0099501
GeneOntologyCellularComponent	synaptic vesicle membrane	DMXL2 DYSF OPRD1 OPRK1 ATP6V1H ATP8A1 SLC17A7 SLC17A6	2.68e-05	179	139	8	GO:0030672
GeneOntologyCellularComponent	transport vesicle membrane	SEC16B DMXL2 DYSF OPRD1 OPRK1 ATP6V1H ATP8A1 SLC17A7 SLC17A6	1.54e-04	293	139	9	GO:0030658
GeneOntologyCellularComponent	dynein complex	DNAH3 DNAH7 DNAH5 DNAH8	4.58e-04	54	139	4	GO:0030286
GeneOntologyCellularComponent	secretory vesicle	DMXL2 SPATA31A3 SPATA31A7 ANXA7 IDH1 DYSF SPATA31A5 OPRD1 OPRK1 ATP6V1H ATP8A1 SPATA31A1 CADPS PYCARD SLC17A7 CDA TSSK4 RHOF SLC17A6	6.02e-04	1246	139	19	GO:0099503
GeneOntologyCellularComponent	collagen type IV trimer	COL4A2 COL4A3	6.47e-04	6	139	2	GO:0005587
GeneOntologyCellularComponent	synaptic vesicle	DMXL2 DYSF OPRD1 OPRK1 ATP6V1H ATP8A1 SLC17A7 SLC17A6	9.11e-04	300	139	8	GO:0008021
GeneOntologyCellularComponent	9+2 motile cilium	DNAH3 CFAP251 DNAH7 PCDH11X DNAH5 TSSK4 DNAH8	1.09e-03	238	139	7	GO:0097729
GeneOntologyCellularComponent	basement membrane collagen trimer	COL4A2 COL4A3	1.20e-03	8	139	2	GO:0098651
GeneOntologyCellularComponent	network-forming collagen trimer	COL4A2 COL4A3	1.20e-03	8	139	2	GO:0098642
GeneOntologyCellularComponent	collagen network	COL4A2 COL4A3	1.20e-03	8	139	2	GO:0098645
GeneOntologyCellularComponent	basement membrane	NPHS1 COL4A2 COL4A3 ADAMTS1 USH2A	1.35e-03	122	139	5	GO:0005604
GeneOntologyCellularComponent	exocytic vesicle	DMXL2 DYSF OPRD1 OPRK1 ATP6V1H ATP8A1 SLC17A7 SLC17A6	1.37e-03	320	139	8	GO:0070382
GeneOntologyCellularComponent	spine apparatus	SYNPO OPRD1	1.53e-03	9	139	2	GO:0097444
GeneOntologyCellularComponent	chromaffin granule membrane	ANXA7 ATP8A1	1.53e-03	9	139	2	GO:0042584
GeneOntologyCellularComponent	intercellular canaliculus	ABCB1 ABCB11	1.53e-03	9	139	2	GO:0046581
GeneOntologyCellularComponent	neuronal dense core vesicle	DMXL2 OPRD1 CADPS	1.75e-03	36	139	3	GO:0098992
GeneOntologyCellularComponent	inner dynein arm	DNAH3 DNAH7	1.91e-03	10	139	2	GO:0036156
GeneOntologyCellularComponent	presynapse	CHRNA6 DMXL2 NLGN1 DYSF OPRD1 OPRK1 ATP6V1H ATP8A1 CADPS SCN1A RIMS4 SLC17A7 USH2A SLC17A6	2.36e-03	886	139	14	GO:0098793
MousePheno	decreased cell proliferation	FAM120B PDGFRB DOCK8 ENPP2 EZH2 BHLHE40 DICER1 LEPR UBE2O SPPL2A PER2 CD19 RPTOR BTK TNRC6A PRKCQ LTB4R CDK2 HELLS	3.89e-06	739	109	19	MP:0000352
Domain	AAA	DNAH3 ABCA1 ABCA2 VWA8 DNAH7 ABCA9 ABCA8 ABCB1 ABCB11 DNAH5 DNAH8	7.70e-09	144	135	11	SM00382
Domain	AAA+_ATPase	DNAH3 ABCA1 ABCA2 VWA8 DNAH7 ABCA9 ABCA8 ABCB1 ABCB11 DNAH5 DNAH8	7.70e-09	144	135	11	IPR003593
Domain	ABC_tran	ABCA1 ABCA2 ABCA9 ABCA8 ABCB1 ABCB11	1.22e-06	48	135	6	PF00005
Domain	ABC_TRANSPORTER_2	ABCA1 ABCA2 ABCA9 ABCA8 ABCB1 ABCB11	1.22e-06	48	135	6	PS50893
Domain	ABC_A	ABCA1 ABCA2 ABCA9 ABCA8	1.24e-06	12	135	4	IPR026082
Domain	ABC_TRANSPORTER_1	ABCA1 ABCA2 ABCA9 ABCA8 ABCB1 ABCB11	1.38e-06	49	135	6	PS00211
Domain	ABC_transporter-like	ABCA1 ABCA2 ABCA9 ABCA8 ABCB1 ABCB11	1.56e-06	50	135	6	IPR003439
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH7 DNAH5 DNAH8	2.47e-06	14	135	4	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH7 DNAH5 DNAH8	2.47e-06	14	135	4	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DNAH7 DNAH5 DNAH8	2.47e-06	14	135	4	IPR013602
Domain	DHC_N2	DNAH3 DNAH7 DNAH5 DNAH8	2.47e-06	14	135	4	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH3 VWA8 DNAH5 DNAH8	2.47e-06	14	135	4	IPR011704
Domain	MT	DNAH3 DNAH7 DNAH5 DNAH8	2.47e-06	14	135	4	PF12777
Domain	AAA_8	DNAH3 DNAH7 DNAH5 DNAH8	2.47e-06	14	135	4	PF12780
Domain	AAA_5	DNAH3 VWA8 DNAH5 DNAH8	2.47e-06	14	135	4	PF07728
Domain	DHC_fam	DNAH3 DNAH7 DNAH5 DNAH8	3.35e-06	15	135	4	IPR026983
Domain	Dynein_heavy	DNAH3 DNAH7 DNAH5 DNAH8	3.35e-06	15	135	4	PF03028
Domain	Dynein_heavy_dom	DNAH3 DNAH7 DNAH5 DNAH8	3.35e-06	15	135	4	IPR004273
Domain	-	DNAH3 ABCA1 ABCA2 VWA8 RTEL1 MYO19 BMS1 DNAH7 DICER1 ABCA9 ABCA8 ABCB1 TRANK1 ABCB11 DNAH5 DNAH8 RHOF HELLS	7.22e-06	746	135	18	3.40.50.300
Domain	P-loop_NTPase	DNAH3 ABCA1 ABCA2 VWA8 RTEL1 MYO19 BMS1 DNAH7 DICER1 ABCA9 ABCA8 ABCB1 TRANK1 ABCB11 DNAH5 DNAH8 RHOF HELLS	3.99e-05	848	135	18	IPR027417
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A5	7.75e-05	12	135	3	PF15371
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A5	7.75e-05	12	135	3	IPR027970
Domain	ABC_transporter_CS	ABCA1 ABCA2 ABCB1 ABCB11	2.36e-04	42	135	4	IPR017871
Domain	Opioid_rcpt	OPRD1 OPRK1	3.08e-04	4	135	2	IPR001418
Domain	C4	COL4A2 COL4A3	7.63e-04	6	135	2	SM00111
Domain	Collagen_VI_NC	COL4A2 COL4A3	7.63e-04	6	135	2	IPR001442
Domain	NC1_IV	COL4A2 COL4A3	7.63e-04	6	135	2	PS51403
Domain	-	COL4A2 COL4A3	7.63e-04	6	135	2	2.170.240.10
Domain	C4	COL4A2 COL4A3	7.63e-04	6	135	2	PF01413
Domain	DHC_N1	DNAH5 DNAH8	1.41e-03	8	135	2	PF08385
Domain	Dynein_heavy_dom-1	DNAH5 DNAH8	1.41e-03	8	135	2	IPR013594
Pathway	KEGG_ABC_TRANSPORTERS	ABCA1 ABCA2 ABCA9 ABCA8 ABCB1 ABCB11	7.40e-07	44	103	6	M11911
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH3 DNAH7 DNAH5 DNAH8	4.15e-05	27	103	4	M47755
Pathway	REACTOME_ORGANIC_ANION_TRANSPORTERS	SLC17A7 SLC5A8 SLC17A6	7.94e-05	12	103	3	M27350
Pathway	REACTOME_ORGANIC_ANION_TRANSPORTERS	SLC17A7 SLC5A8 SLC17A6	7.94e-05	12	103	3	MM15087
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	3.64e-09	6	139	4	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	3.64e-09	6	139	4	25930072
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ABCA2 SZT2 VWA8 PIEZO1 SUN1 BMS1 SYNPO DICER1 UBE2O TRANK1 MAST4 SMG7 RPTOR TNRC6A	3.09e-08	529	139	14	14621295
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH3 DNAH7 DNAH5 DNAH8	2.37e-07	14	139	4	9373155
Pubmed	Large-scale identification of genes implicated in kidney glomerulus development and function.	NPHS1 COL4A2 COL4A3 PDGFRB SYNPO	2.40e-07	34	139	5	16498405
Pubmed	Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes.	ABCA1 ABCA9 ABCA8	6.21e-07	5	139	3	12532264
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH3 DNAH5 DNAH8	2.16e-06	7	139	3	9256245
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	2.44e-06	24	139	4	32212159
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	CHRNA6 NLGN1 LEPR OPRD1 OPRK1 ABCB1 SLC17A7 NRG3 SLC17A6	3.61e-06	300	139	9	19086053
Pubmed	Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.	ABCA2 ABCA8 ABCB1	5.16e-06	9	139	3	21707071
Pubmed	Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy.	NPHS1 COL4A3 SYNPO	5.16e-06	9	139	3	35499085
Pubmed	Inhibitory effects of Robo2 on nephrin: a crosstalk between positive and negative signals regulating podocyte structure.	NPHS1 PDGFRB SYNPO	7.34e-06	10	139	3	22840396
Pubmed	Diversification of stem cell molecular repertoire by alternative splicing.	BRIX1 DOCK8 PYCARD BTK	1.16e-05	35	139	4	16183747
Pubmed	Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites.	SLC17A7 SLC17A6	1.59e-05	2	139	2	15118123
Pubmed	ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy.	ABCB1 ABCB11	1.59e-05	2	139	2	25661339
Pubmed	ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease.	ABCA1 ABCA2	1.59e-05	2	139	2	15649702
Pubmed	Transiently increased colocalization of vesicular glutamate transporters 1 and 2 at single axon terminals during postnatal development of mouse neocortex: a quantitative analysis with correlation coefficient.	SLC17A7 SLC17A6	1.59e-05	2	139	2	18028110
Pubmed	Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment.	ABCA1 SCN1A	1.59e-05	2	139	2	17322896
Pubmed	μ-Opioid receptor antibody reveals tissue-dependent specific staining and increased neuronal μ-receptor immunoreactivity at the injured nerve trunk in mice.	OPRD1 OPRK1	1.59e-05	2	139	2	24278116
Pubmed	ABC transporters: from microorganisms to man.	ABCA1 ABCA2	1.59e-05	2	139	2	1282354
Pubmed	Phosphorylation of CDK2 at threonine 160 regulates meiotic pachytene and diplotene progression in mice.	SUN1 CDK2	1.59e-05	2	139	2	24797635
Pubmed	Modulation of expressivity in PDGFRB-related infantile myofibromatosis: a role for PTPRG?	PDGFRB PTPRG	1.59e-05	2	139	2	25158255
Pubmed	Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia.	SLC17A7 SLC17A6	1.59e-05	2	139	2	18155679
Pubmed	Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis.	ABCA1 EZH2	1.59e-05	2	139	2	27295295
Pubmed	Haploinsufficiency of VGluT1 but not VGluT2 impairs extinction of spatial preference and response suppression.	SLC17A7 SLC17A6	1.59e-05	2	139	2	23396167
Pubmed	Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning.	SLC17A7 SLC17A6	1.59e-05	2	139	2	19574394
Pubmed	Molecular cloning of a novel brain-type Na(+)-dependent inorganic phosphate cotransporter.	SLC17A7 SLC17A6	1.59e-05	2	139	2	10820226
Pubmed	Disruption of VGLUT1 in Cholinergic Medial Habenula Projections Increases Nicotine Self-Administration.	SLC17A7 SLC17A6	1.59e-05	2	139	2	34876472
Pubmed	Interplay between VGLUT isoforms and endophilin A1 regulates neurotransmitter release and short-term plasticity.	SLC17A7 SLC17A6	1.59e-05	2	139	2	21435559
Pubmed	Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer.	ABCB1 CDA	1.59e-05	2	139	2	25691056
Pubmed	The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions.	OPRD1 OPRK1	1.59e-05	2	139	2	16331961
Pubmed	Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40.	BHLHE40 ABCB1	1.59e-05	2	139	2	36931039
Pubmed	Identification of kappa- and delta-opioid receptor transcripts in immune cells.	OPRD1 OPRK1	1.59e-05	2	139	2	7649271
Pubmed	miRNAs are required for generating a time delay critical for the circadian oscillator.	DICER1 PER2	1.59e-05	2	139	2	24094851
Pubmed	Differential sorting of the vesicular glutamate transporter 1 into a defined vesicular pool is regulated by light signaling involving the clock gene Period2.	PER2 SLC17A7	1.59e-05	2	139	2	16595674
Pubmed	Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.	SLC17A7 SLC17A6	1.59e-05	2	139	2	17531353
Pubmed	Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.	EZH2 DICER1	1.59e-05	2	139	2	26631032
Pubmed	Two distinct GUCY2C circuits with PMV (hypothalamic) and SN/VTA (midbrain) origin.	LEPR GUCY2C	1.59e-05	2	139	2	31485718
Pubmed	ABCA1 Is Coordinated with ABCB1 in the Arsenic-Resistance of Human Cells.	ABCA1 ABCB1	1.59e-05	2	139	2	29951962
Pubmed	Association of the ATP-binding cassette transporter A1 R230C variant with early-onset type 2 diabetes in a Mexican population.	ABCA1 ABCB1	1.59e-05	2	139	2	18003760
Pubmed	Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement.	EZH2 CD19	1.59e-05	2	139	2	12496962
Pubmed	Impairment of VGLUT2 but not VGLUT1 signaling reduces neuropathy-induced hypersensitivity.	SLC17A7 SLC17A6	1.59e-05	2	139	2	19171494
Pubmed	MicroRNAs prevent the generation of autoreactive antibodies.	DICER1 CD19	1.59e-05	2	139	2	21093320
Pubmed	mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia.	CD19 RPTOR	1.59e-05	2	139	2	37775560
Pubmed	Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.	CD19 BTK	1.59e-05	2	139	2	10201980
Pubmed	Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.	ENPP2 LEPR	1.59e-05	2	139	2	12642576
Pubmed	Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.	OPRD1 OPRK1	1.59e-05	2	139	2	8393575
Pubmed	Malaria in pregnancy regulates P-glycoprotein (P-gp/Abcb1a) and ABCA1 efflux transporters in the Mouse Visceral Yolk Sac.	ABCA1 ABCB1	1.59e-05	2	139	2	32779889
Pubmed	Regulations of opioid dependence by opioid receptor types.	OPRD1 OPRK1	1.59e-05	2	139	2	11316510
Pubmed	[Pharmacogenetic criteria of drug-resistant epilepsy].	ABCB1 SCN1A	1.59e-05	2	139	2	23786015
Pubmed	Expression of vesicular glutamate transporters type 1 and 2 in sensory and autonomic neurons innervating the mouse colorectum.	SLC17A7 SLC17A6	1.59e-05	2	139	2	21800314
Pubmed	LncRNA LINC00968 accelerates the proliferation and fibrosis of diabetic nephropathy by epigenetically repressing p21 via recruiting EZH2.	EZH2 LEPR	1.59e-05	2	139	2	30197001
Pubmed	The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.	OPRD1 OPRK1	1.59e-05	2	139	2	17622222
Pubmed	BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes.	EZH2 CD19	1.59e-05	2	139	2	35226736
Pubmed	Chromatin changes in dicer-deficient mouse embryonic stem cells in response to retinoic acid induced differentiation.	EZH2 DICER1	1.59e-05	2	139	2	24040281
Pubmed	Expression of the vesicular glutamate transporters-1 and -2 in adult mouse dorsal root ganglia and spinal cord and their regulation by nerve injury.	SLC17A7 SLC17A6	1.59e-05	2	139	2	17577523
Pubmed	ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma.	ABCA1 ABCB1	1.59e-05	2	139	2	32155954
Pubmed	Cloning, characterization and tissue distribution of the rat ATP-binding cassette (ABC) transporter ABC2/ABCA2.	ABCA1 ABCA2	1.59e-05	2	139	2	10970803
Pubmed	Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.	SLC17A7 SLC17A6	1.59e-05	2	139	2	19839996
Pubmed	Compensatory role of P-glycoproteins in knockout mice lacking the bile salt export pump.	ABCB1 ABCB11	1.59e-05	2	139	2	19650158
Pubmed	Vesicular glutamate transporters VGLUT1 and VGLUT2 in the developing mouse barrel cortex.	SLC17A7 SLC17A6	1.59e-05	2	139	2	17289331
Pubmed	Dock8 regulates BCR signaling and activation of memory B cells via WASP and CD19.	DOCK8 CD19	1.59e-05	2	139	2	29472447
Pubmed	Vesicular glutamate transporters define two sets of glutamatergic afferents to the somatosensory thalamus and two thalamocortical projections in the mouse.	SLC17A7 SLC17A6	1.59e-05	2	139	2	18181146
Pubmed	ABC proteins protect the human body and maintain optimal health.	ABCA1 ABCB1	1.59e-05	2	139	2	21389634
Pubmed	Cloning of two novel ABC transporters mapping on human chromosome 9.	ABCA1 ABCA2	1.59e-05	2	139	2	8088782
Pubmed	Bifunctional lipocalin ameliorates murine immune complex-induced acute lung injury.	C5 LTB4R	1.59e-05	2	139	2	23625922
Pubmed	Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.	OPRD1 OPRK1	1.59e-05	2	139	2	24923251
Pubmed	Interactive effect between ATPase-related genes and early-life tobacco smoke exposure on bronchial hyper-responsiveness detected in asthma-ascertained families.	ABCA1 ATP8A1	1.59e-05	2	139	2	30282721
Pubmed	G-protein-coupled receptor heterodimerization modulates receptor function.	OPRD1 OPRK1	1.59e-05	2	139	2	10385123
Pubmed	Altered vesicular glutamate transporter distributions in the mouse cochlear nucleus following cochlear insult.	SLC17A7 SLC17A6	1.59e-05	2	139	2	26705736
Pubmed	Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia.	NPHS1 SYNPO	1.59e-05	2	139	2	17255128
Pubmed	Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.	OPRD1 OPRK1	1.59e-05	2	139	2	16712978
Pubmed	Postnatal changes of vesicular glutamate transporter (VGluT)1 and VGluT2 immunoreactivities and their colocalization in the mouse forebrain.	SLC17A7 SLC17A6	1.59e-05	2	139	2	16217795
Pubmed	Salmonella Promotes Its Own Survival in B Cells by Inhibiting Autophagy.	CD19 RPTOR	1.59e-05	2	139	2	35805144
Pubmed	MOR is not enough: identification of novel mu-opioid receptor interacting proteins using traditional and modified membrane yeast two-hybrid screens.	DOK5 OPRD1 OPRK1	2.74e-05	15	139	3	23840749
Pubmed	Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism.	NLGN1 SLC17A7 SLC17A6	2.74e-05	15	139	3	18227507
Pubmed	Large-scale structural analysis of the classical human protein tyrosine phosphatome.	PDGFRB LEPR PTPRG ALK	3.81e-05	47	139	4	19167335
Pubmed	Vesicular glutamate transporters use flexible anion and cation binding sites for efficient accumulation of neurotransmitter.	SLC17A7 SLC17A6	4.75e-05	3	139	2	25433636
Pubmed	Human collagen genes encoding basement membrane alpha 1 (IV) and alpha 2 (IV) chains map to the distal long arm of chromosome 13.	COL4A2 COL4A3	4.75e-05	3	139	2	3025878
Pubmed	Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2.	EZH2 CDK2	4.75e-05	3	139	2	20935635
Pubmed	Quantitative autoradiography of mu-,delta- and kappa1 opioid receptors in kappa-opioid receptor knockout mice.	OPRD1 OPRK1	4.75e-05	3	139	2	10082819
Pubmed	VGLUT1 Binding to Endophilin or Intersectin1 and Dynamin Phosphorylation in a Diurnal Context.	PER2 SLC17A7	4.75e-05	3	139	2	29199069
Pubmed	Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.	OPRD1 OPRK1	4.75e-05	3	139	2	18537939
Pubmed	Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma.	ABCB1 CD19	4.75e-05	3	139	2	21599592
Pubmed	MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival.	DICER1 CD19	4.75e-05	3	139	2	20587524
Pubmed	Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.	TUB LEPR	4.75e-05	3	139	2	14679177
Pubmed	Cutting Edge: ROR1/CD19 Receptor Complex Promotes Growth of Mantle Cell Lymphoma Cells Independently of the B Cell Receptor-BTK Signaling Pathway.	CD19 BTK	4.75e-05	3	139	2	31534006
Pubmed	Opioid receptors: from binding sites to visible molecules in vivo.	OPRD1 OPRK1	4.75e-05	3	139	2	18718480
Pubmed	Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.	COL4A3 LEPR	4.75e-05	3	139	2	27927599
Pubmed	Docking and homology modeling explain inhibition of the human vesicular glutamate transporters.	SLC17A7 SLC17A6	4.75e-05	3	139	2	17660252
Pubmed	Sociability and synapse subtype-specific defects in mice lacking SRPX2, a language-associated gene.	SLC17A7 SLC17A6	4.75e-05	3	139	2	29920554
Pubmed	Leukotriene B4-mediated sterile inflammation promotes susceptibility to sepsis in a mouse model of type 1 diabetes.	LEPR LTB4R	4.75e-05	3	139	2	25628460
Pubmed	Heterodimerization of mu and delta opioid receptors: A role in opiate synergy.	OPRD1 OPRK1	4.75e-05	3	139	2	11069979
Pubmed	Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*.	OPRD1 OPRK1	4.75e-05	3	139	2	19032295
Pubmed	The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice.	OPRD1 OPRK1	4.75e-05	3	139	2	15090050
Pubmed	Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression.	STRBP DICER1	4.75e-05	3	139	2	38280476
Pubmed	Euglycemia Restoration by Central Leptin in Type 1 Diabetes Requires STAT3 Signaling but Not Fast-Acting Neurotransmitter Release.	LEPR SLC17A6	4.75e-05	3	139	2	26822087
Pubmed	Nephrin, a transmembrane protein, is involved in pancreatic beta-cell survival signaling.	NPHS1 LEPR	4.75e-05	3	139	2	25448064
Pubmed	Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.	SLC17A7 SLC17A6	4.75e-05	3	139	2	26332770
Pubmed	Lack of evidence for vesicular glutamate transporter expression in mouse astrocytes.	SLC17A7 SLC17A6	4.75e-05	3	139	2	23467360
Cytoband	8q11.2	OPRK1 ATP6V1H	5.44e-05	4	139	2	8q11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr9q12	SPATA31A7 SPATA31A5	2.52e-04	8	139	2	chr9q12
GeneFamily	ATP binding cassette subfamily A	ABCA1 ABCA2 ABCA9 ABCA8	6.04e-07	14	92	4	805
GeneFamily	Dyneins, axonemal	DNAH3 DNAH7 DNAH5 DNAH8	1.42e-06	17	92	4	536
GeneFamily	Opioid receptors	OPRD1 OPRK1	1.53e-04	4	92	2	245
GeneFamily	Immunoglobulin like domain containing	NPHS1 PDGFRB LEPR CD19 MYOM2 IL1RAP	4.56e-04	193	92	6	594
GeneFamily	Fibronectin type III domain containing	NPHS1 PTPRG MYOM2 USH2A TNXB	1.35e-03	160	92	5	555
GeneFamily	ATP binding cassette subfamily B	ABCB1 ABCB11	1.37e-03	11	92	2	806
GeneFamily	DNA helicases	RTEL1 HELLS	3.31e-03	17	92	2	1167
CoexpressionAtlas	kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000	NPHS1 COL4A3 FILIP1 ABCA2 VWA8 PDGFRB ANXA7 CYP27A1 SYNPO ABLIM3 ABCA9 FRY HOXC4 SPPL2A ATP8A1 MAST4 TBC1D1 MLLT11 MYOM2	9.53e-07	838	131	19	gudmap_kidney_adult_Podocyte_MafB_1000
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTS1 PDGFRB SLC19A2 NLGN1 TUB ABCA9 ABCA8 PTPRG TNXB	1.13e-08	195	139	9	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A2 COL4A3 ADAMTS1 NLGN1 ABCA9 ABCA8 LEPR PTPRG TNXB	1.35e-08	199	139	9	9c2db0bb94cba71a3cc1827844da090e213e0258
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	COL4A2 COL4A3 ADAMTS1 PDGFRB SLC19A2 ABCA9 LEPR MLLT11	1.47e-07	189	139	8	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	DOK5 PDGFRB NLGN1 ABCA9 ABCA8 LEPR TNXB STEAP1	1.66e-07	192	139	8	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	VE-naiveBc-\|VE / Condition, Cell_class and T cell subcluster	COL4A3 STRBP SYNPO CD19 GUCY2C CADPS BTK DNAH8	1.66e-07	192	139	8	bca2aec4811627225fccd92abe2f3b1ba729c9ce
ToppCell	VE-naiveBc\|VE / Condition, Cell_class and T cell subcluster	COL4A3 STRBP SYNPO CD19 GUCY2C CADPS BTK DNAH8	1.66e-07	192	139	8	87cdda9a170f6f2fa56d0ed1d3fd2f93bfe09aa1
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A2 ADAMTS1 PDGFRB SLC19A2 NLGN1 ABCA9 ABCA8 TNXB	1.73e-07	193	139	8	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	COL4A2 COL4A3 ADAMTS1 PDGFRB SLC19A2 ABCA9 LEPR MLLT11	1.80e-07	194	139	8	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	5'-Adult-Appendix-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A2 FILIP1 ADAMTS1 PDGFRB SLC19A2 ABCA9 ABCA8 PTPRG	2.02e-07	197	139	8	b11a5d909942a4299cbc0b27332b1a3f66f3bccd
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	COL4A2 ADAMTS1 PDGFRB ABLIM3 ABCA9 ABCA8 PTPRG TNXB	2.18e-07	199	139	8	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-I_(AT1)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL4A2 COL4A3 ABCA1 PIEZO1 SYNPO ABCA8 WWC2 RHOF	2.18e-07	199	139	8	5a002d49a8b84c158f7b4d7a3e78e6a937757bb7
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A2 COL4A3 ADAMTS1 NLGN1 ABCA9 ABCA8 PTPRG TNXB	2.18e-07	199	139	8	3835452e4848d7f7dd8651c17b746b271ef39688
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	COL4A2 ABLIM3 ABCA9 ABCA8 ABCB1 FRY MAST4 PTPRG	2.27e-07	200	139	8	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A2 PDGFRB SLC19A2 NLGN1 ABCA9 ABCA8 LEPR TNXB	2.27e-07	200	139	8	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	COL4A2 ABLIM3 ABCA9 ABCA8 ABCB1 FRY MAST4 PTPRG	2.27e-07	200	139	8	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	COL4A2 ABLIM3 ABCA9 ABCA8 ABCB1 FRY MAST4 PTPRG	2.27e-07	200	139	8	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	COL4A2 ABLIM3 ABCA9 ABCA8 ABCB1 FRY MAST4 PTPRG	2.27e-07	200	139	8	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	COL4A2 ABLIM3 ABCA9 ABCA8 ABCB1 FRY MAST4 PTPRG	2.27e-07	200	139	8	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	COL4A2 ABLIM3 ABCA9 ABCA8 ABCB1 FRY MAST4 PTPRG	2.27e-07	200	139	8	7136936d05ab344a560cf159684c881063b5430d
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A2 ABCA1 PDGFRB ABCA9 ABCA8 LEPR PTPRG TNXB	2.27e-07	200	139	8	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A2 ABCA1 ADAMTS1 ABCA8 PTPRG PCDH11X ALK	1.27e-06	174	139	7	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL4A2 FILIP1 ADAMTS1 PDGFRB FRY PTPRG TBC1D1	1.32e-06	175	139	7	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	normal-na-Lymphocytic_B-B_mem-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	COL4A3 STRBP SYNPO CD19 CADPS BTK DNAH8	1.72e-06	182	139	7	ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870
ToppCell	NS-critical-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	COL4A2 ADAMTS1 ENPP2 NLGN1 ABCA9 ABCA8 NRG3	1.72e-06	182	139	7	dd1c59babf7211362452e3e264009d70004d99f6
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	COL4A2 SEC16B DOCK8 NLGN1 MAST4 SLC5A8 ACMSD	1.85e-06	184	139	7	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	PDGFRB NLGN1 ABCA9 ABCA8 LEPR PTPRG TNXB	1.92e-06	185	139	7	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	FILIP1 EZH2 ABCA9 ABCA8 LEPR CDA TNXB	1.99e-06	186	139	7	6259f0f2d5bc863782d09a901d6be2f387d1f074
ToppCell	Control-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	COL4A2 COL4A3 ABCA1 SYNPO ABCA8 WWC2 NRG3	2.06e-06	187	139	7	3a032432f780525f4f4c2a358897d9989b1ecae7
ToppCell	COVID-19-kidney-Stressed_PCT\|kidney / Disease (COVID-19 only), tissue and cell type	ENPP2 NLGN1 ABCB1 MAST4 SLC5A8 ACMSD HAO2	2.06e-06	187	139	7	acd305475f3609800af0d7bc68d83ef41228080b
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	DOK5 ADAMTS1 NLGN1 ABCA9 ABCA8 LEPR TNXB	2.13e-06	188	139	7	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	Multiciliated\|World / shred by cell class for nasal brushing	FILIP1 DNAH3 CFAP251 HOATZ GPR162 DNAH7 DNAH5	2.21e-06	189	139	7	34b110aef839376228c5a403a6b5047a945f472b
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	DOK5 PDGFRB NLGN1 ABCA9 ABCA8 TNXB STEAP1	2.29e-06	190	139	7	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	pdx-Tumor_cells-T8\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SEC16B ABCA1 CYP27A1 CPS1 ABCB11 NRG3 IL1RAP	2.29e-06	190	139	7	b05db0de9b6ae01dd30074453f7de44f7397631e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A3 STRBP EZH2 GTF3C4 FBXO10 CD19 DNAH8	2.29e-06	190	139	7	0db545a4cba7534bad2693e0d565cde7dbc7a586
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZDHHC2 FILIP1 ABCA1 ENPP2 CADPS FAM151A USH2A	2.45e-06	192	139	7	5b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LIPK OPRK1 GUCY2C FAM151A CYP4F22 USH2A DNAH8	2.54e-06	193	139	7	315840bc48899f3a36d57b19197509de19716e3d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS1 NLGN1 DNAH7 PER2 ACMSD NRG3 DNAH5	2.54e-06	193	139	7	ca7c0a4ceb05bced90f6cdc53d278e547fb241e9
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUB TRANK1 CADPS SLC17A7 KCNS1 NRG3 SLC17A6	2.54e-06	193	139	7	461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUB TRANK1 CADPS SLC17A7 KCNS1 NRG3 SLC17A6	2.54e-06	193	139	7	0dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 CFAP251 PDGFRB ABCA9 ABCA8 TRANK1 TNXB	2.62e-06	194	139	7	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL4A3 FILIP1 TMTC2 WWC2 ATP8A1 MAST4 SCN1A	2.62e-06	194	139	7	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 CFAP251 PDGFRB ABCA9 ABCA8 TRANK1 TNXB	2.62e-06	194	139	7	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	COPD-Stromal-Myofibroblast\|COPD / Disease state, Lineage and Cell class	COL4A2 FILIP1 ADAMTS1 PDGFRB ABCA8 PTPRG STEAP1	2.81e-06	196	139	7	af206bb5bbb8b604a6212acd79878bcc3d326cec
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 CFAP251 HOATZ DNAH7 MAST4 PTPRG DNAH5	2.81e-06	196	139	7	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS1 PDGFRB SLC19A2 PTPRG MLLT11 HAO2 STEAP1	2.81e-06	196	139	7	46d665de09f8164690b9a3e0acf0b0afa3f81b3d
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 CFAP251 HOATZ DNAH7 MAST4 PTPRG DNAH5	2.81e-06	196	139	7	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	distal-mesenchymal-Lipofibroblast-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ADAMTS1 PDGFRB SLC19A2 ABCA8 MLLT11 HAO2 STEAP1	2.90e-06	197	139	7	865010edcd7e3f79f505fcef7b33882095994aa8
ToppCell	distal-mesenchymal-Lipofibroblast\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ADAMTS1 PDGFRB SLC19A2 ABCA8 MLLT11 HAO2 STEAP1	2.90e-06	197	139	7	ceb83bdef16b58ee16193413bfb006f7715728b2
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FILIP1 DNAH3 CFAP251 HOATZ GPR162 DNAH7 DNAH5	2.90e-06	197	139	7	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	normal_Lung-Epithelial_cells-AT1\|Epithelial_cells / Location, Cell class and cell subclass	COL4A2 COL4A3 ABCA1 SYNPO ABCA8 WWC2 RHOF	2.90e-06	197	139	7	7d19b93d6853828e2a036e37c4887edb1de4503c
ToppCell	COPD-Stromal\|COPD / Disease state, Lineage and Cell class	COL4A2 ADAMTS1 PDGFRB ABCA9 ABCA8 PTPRG STEAP1	2.90e-06	197	139	7	d5390d86acaa8c39f1da893e8d2271f9ed2951d7
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FILIP1 DNAH3 CFAP251 HOATZ GPR162 DNAH7 DNAH5	2.90e-06	197	139	7	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL4A2 DOK5 PDGFRB NLGN1 ABLIM3 ABCA8 PTPRG	3.00e-06	198	139	7	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	3'-Adult-LymphNode-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FILIP1 ADAMTS1 PDGFRB SLC19A2 ABCA9 ABCA8 TNXB	3.00e-06	198	139	7	698166b4ca173176ed563af6a1efc8c7d0a18e0b
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A3 FILIP1 TMTC2 WWC2 ATP8A1 MAST4 SCN1A	3.10e-06	199	139	7	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	mild-B_memory\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	COL4A3 STRBP SYNPO FBXO10 CD19 BTK DNAH8	3.10e-06	199	139	7	025bb65629d9e20c374e8f1ba08c36d1bb569190
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS1 ENPP2 SYNPO ABLIM3 LEPR MAST4 PTPRG	3.10e-06	199	139	7	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	ADAMTS1 PDGFRB ABCA9 ABCA8 MLLT11 TNXB STEAP1	3.21e-06	200	139	7	2c5626ea8fb4b702d4560117e53edf6cfcf1971e
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	COL4A2 ADAMTS1 PDGFRB ABCA9 ABCA8 TNXB STEAP1	3.21e-06	200	139	7	954fee8425673e76198be414f5f6c4e3597c1919
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS1 PDGFRB ABCA9 ABCA8 LEPR TNXB STEAP1	3.21e-06	200	139	7	2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A2 PDGFRB ABCA9 ABCA8 LEPR PTPRG TNXB	3.21e-06	200	139	7	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A2 PDGFRB ABCA9 ABCA8 LEPR PTPRG TNXB	3.21e-06	200	139	7	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	facs-Aorta-Heart-3m-Myeloid-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPHS1 UBE2O CADPS SCN1A SLC17A7 USH2A	5.00e-06	139	139	6	22a769d5195ed761ef333ef542746e1ba617a698
ToppCell	facs-Aorta-Heart-3m-Myeloid-professional_antigen_presenting_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPHS1 UBE2O CADPS SCN1A SLC17A7 USH2A	5.00e-06	139	139	6	292533e04178dd36d57377562077f9deb2cb9746
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	OR13F1 TMTC2 OPRD1 PCDH11X ABCB11 CDA	5.89e-06	143	139	6	24fd24846fbef049af669a57d42fcc18928d2b27
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PLA2G7 SLC29A3 VWA8 CYP27A1 PCDH11X C5	7.45e-06	149	139	6	13b445c13bb8f31ff0876addd1baf969ae220ea3
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A3 FILIP1 DNAH3 LRRC37A2 CD19 DNAH8	7.74e-06	150	139	6	53de595376a9fc92491dfd58ff25938b0bf79903
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EYS ABCB11 CYP4F22 USH2A DNAH8 ALK	7.74e-06	150	139	6	0205318a870e091add66ee4305747dda9f51510d
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A3 FILIP1 DNAH3 LRRC37A2 CD19 DNAH8	7.74e-06	150	139	6	e4b40b3243ed26d0c46bf196ac06e148834e7ed2
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	PLA2G7 DOCK8 CYP27A1 WWC2 FRRS1 DNAH5	8.04e-06	151	139	6	4533bccc996395f74b16af939ce79b6fe253c073
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	PLA2G7 DOCK8 CYP27A1 WWC2 FRRS1 DNAH5	8.04e-06	151	139	6	edb2f59789c295838d2030b80c792cbea25eaa3d
ToppCell	AT1-AT2_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	COL4A2 COL4A3 SYNPO RGS11 C5 SLC5A8	9.34e-06	155	139	6	010e45ef4b505bf419ea41e4d1619521d1c78319
ToppCell	facs-Liver-Hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEC16B ENPP2 SLC19A2 CPS1 ABCB11 IL1RAP	9.69e-06	156	139	6	e2cda3ad4e5f44a80133864c5a38b766afb952ce
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A3 FILIP1 DNAH3 LRRC37A2 CD19 DNAH8	9.69e-06	156	139	6	a5930b455e5c8586c43c50106ab4d8a1e5e9e3d6
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DNAH3 EYS CADPS USH2A DNAH8 ALK	1.08e-05	159	139	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	DNAH3 EYS CADPS CYP4F22 USH2A ALK	1.24e-05	163	139	6	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZDHHC2 RGS11 CCN6 PYCARD PRKCQ RHOF	1.29e-05	164	139	6	1a9b444d2c6abcc83d4355ec5228b27541df2bd0
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D32 ATP8A1 MAST4 PER2 DDHD2	1.41e-05	98	139	5	95162072f3afc95e46f29db3d79ebd930bc09726
ToppCell	droplet-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENPP2 IDH1 FAM151A CDA SLC5A8 HAO2	1.48e-05	168	139	6	dd48da83c32d41a62f80cd7e5e5c64e42776fa27
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NBPF3 COL4A2 ABCA1 ADAMTS1 ABCA8 PTPRG	1.53e-05	169	139	6	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	RA-01._Fibroblast_I\|RA / Chamber and Cluster_Paper	COL4A2 COL4A3 TMTC2 ABCA9 ABCA8 PTPRG	1.53e-05	169	139	6	6373562ab3b1765060212a6a53d6543e7e942e80
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CFAP251 HOATZ GPR162 DNAH7 DNAH5	1.74e-05	173	139	6	c3762655caa79ac4879876f470d32578a3c93b01
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	PDGFRB ABCA9 ABCA8 LEPR TNXB STEAP1	1.92e-05	176	139	6	2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	COL4A3 FILIP1 ADAMTS1 SYNPO TNXB STEAP1	1.92e-05	176	139	6	bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	PDGFRB ABCA9 ABCA8 LEPR TNXB STEAP1	1.92e-05	176	139	6	f33ab41d121b59d871ad7d48ca021524a027d2ef
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL4A2 DOK5 PDGFRB ABCA9 ABCA8 STEAP1	1.98e-05	177	139	6	cdfd2f0ee2f692271b1525e414b0f645cdadb1f6
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	COL4A3 ADAMTS1 SYNPO PTPRG TNXB STEAP1	1.98e-05	177	139	6	3d955ea938a1d2fb1b6d68d4997fd454bd632dfc
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS1 SLC19A2 TMTC2 ABCA9 PTPRG MLLT11	1.98e-05	177	139	6	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	COVID-19_Moderate-B_intermediate\|COVID-19_Moderate / disease group, cell group and cell class	COL4A3 STRBP SYNPO CD19 GUCY2C DNAH8	1.98e-05	177	139	6	68e3d12a0c048a2d0f1b9680c7338a35855bba30
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL4A2 DOK5 PDGFRB ABCA9 ABCA8 STEAP1	1.98e-05	177	139	6	db222faaecbe5600da39277243c4e7e764eb63c9
ToppCell	356C-Fibroblasts-Fibroblast-E-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CPS1 ABCA9 ABCA8 LEPR TNXB STEAP1	2.05e-05	178	139	6	a493a277d175e5e153410a745b26ebe2e0839ea0
ToppCell	356C-Fibroblasts-Fibroblast-E\|356C / Donor, Lineage, Cell class and subclass (all cells)	CPS1 ABCA9 ABCA8 LEPR TNXB STEAP1	2.05e-05	178	139	6	371218babddfd3d8a7bb82a46ce65327ee3fcf12
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 FILIP1 CFAP251 ADAMTS1 ABCA9 ABCA8	2.05e-05	178	139	6	d4ecb84e9b1f4ec49c519321156aa10f9bd34cce
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A2 FILIP1 FBXO10 MAST4 DNAH8 TNXB	2.11e-05	179	139	6	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL4A2 ADAMTS1 PDGFRB FRY TBC1D1 MYOM2	2.11e-05	179	139	6	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A2 COL4A3 FILIP1 ABCA8 WWC2 NRG3	2.11e-05	179	139	6	4f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell	Endothelial\|World / shred by cell class for turbinate	COL4A2 ADAMTS1 ABLIM3 ABCA8 ABCB1 TNXB	2.11e-05	179	139	6	052b2681974be00efb8503fa4e2c85d91d5ebd06
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CFAP251 STRBP HOATZ DNAH7 DNAH5	2.18e-05	180	139	6	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	RA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL4A2 COL4A3 TMTC2 ABCA9 ABCA8 PTPRG	2.25e-05	181	139	6	2b6ddeb53a79a658e2ba78527ff48c155b20daa6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN1 ABLIM3 MAST4 SLC5A8 ACMSD HAO2	2.25e-05	181	139	6	9542c19edc9bd2cba68c01c2a8407705398e3011
Drug	Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; MCF7; HT_HG-U133A	CHRNA6 ABCA1 ABCA2 SZT2 PDGFRB SIGLEC8 ENPP2 CPS1 LEPR CCN6	3.02e-07	198	135	10	3550_UP
Drug	7-hydroxymitragynine	OPRD1 OPRK1 ABCB1	8.12e-07	4	135	3	ctd:C482678
Drug	Dextropropoxyphene	OPRD1 OPRK1 ABCB1	7.01e-06	7	135	3	ctd:D011431
Drug	Dtds	OPRK1 CDA CDK2	7.01e-06	7	135	3	CID000130348
Drug	SNC-121	OPRD1 OPRK1 ABCB1	1.12e-05	8	135	3	CID000197687
Drug	Betamethasone-d5	COL4A3 CHRNA6 PDGFRB ENPP2 ANXA7 CYP27A1 CPS1 GPR162 ABCB1 CCN6 CD19 PYCARD ABCB11 CYP4F22 PRKCQ MYOM2 MPHOSPH9 LTB4R HSD17B3 IL1RAP RHOF CDK2	1.29e-05	1340	135	22	CID000003003
Drug	Morphine	DNAH3 MYO19 CYP27A1 EZH2 LEPR OPRD1 OPRK1 ABCB1 PER2 PYCARD SLC17A7 SLC17A6	1.45e-05	446	135	12	ctd:D009020
Drug	Norfloxacin [70458-96-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A	COL4A3 DMXL2 ABCA1 ENPP2 TUB TRANK1 PER2 KCNS1	2.36e-05	197	135	8	2253_UP
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A	SZT2 BHLHE40 LEPR FRY MAST4 SMG7 KCNS1 HSD17B3	2.45e-05	198	135	8	7232_UP
Drug	Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; HL60; HT_HG-U133A	PLA2G7 DMXL2 SLC29A3 ENPP2 CPS1 SMG7 LTB4R IL1RAP	2.45e-05	198	135	8	3033_DN
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A	DMXL2 CYP27A1 SYNPO RGS11 PER2 SLC17A7 KCNS1 HSD17B3	2.45e-05	198	135	8	2286_UP
Drug	silychristin	ABCB1 ABCB11 ALK CDK2	2.50e-05	29	135	4	CID000441764
Drug	SbCl5	ZDHHC2 GPR162 ABCB1	3.25e-05	11	135	3	CID000024294
Drug	erinacine E	OPRD1 OPRK1	3.49e-05	2	135	2	CID005317180
Drug	Dynorphin (1-11)	OPRD1 OPRK1	3.49e-05	2	135	2	CID003086114
Drug	(-)-EKC	OPRD1 OPRK1	3.49e-05	2	135	2	CID000042800
Drug	2-aminooxazole	OPRD1 OPRK1	3.49e-05	2	135	2	CID000558521
Drug	MR-1353	OPRD1 OPRK1	3.49e-05	2	135	2	CID000197198
Drug	GSK343	EZH2 DICER1	3.49e-05	2	135	2	ctd:C586265
Drug	trefentanil	OPRD1 OPRK1	3.49e-05	2	135	2	CID000060727
Drug	Oxycodone	ADAMTS1 CYP27A1 ABCA8 OPRD1 OPRK1 PYCARD HAO2	3.64e-05	153	135	7	ctd:D010098
Drug	dicyclohexyl phthalate	ABCA1 PDGFRB STRBP CPS1 EZH2 DICER1 OPRK1 PER2 CADPS BTK ABCB11 PRKCQ SLC5A8 MTX1 ALK CDK2	3.70e-05	836	135	16	ctd:C036042
Drug	Adenosine triphosphate	ABCA1 ABCB1 ABCB11 ALK	4.23e-05	33	135	4	DB00171
Drug	AC1L2AC4	ABCB1 SPPL2A ABCB11	4.31e-05	12	135	3	CID000068732
Drug	pyrazinamide	EZH2 DICER1 TBC1D1 ACMSD RHOF	5.26e-05	68	135	5	CID000001046
Drug	asimadoline	OPRD1 OPRK1 ABCB1	5.58e-05	13	135	3	CID000179340
Drug	AC1NAE4O	PLA2G7 ABCA1 ABCB1 WWC2 PYCARD ABCB11	6.44e-05	115	135	6	CID004475485
Drug	Cholic Acid	ABCA1 CYP27A1 ABCB1 ABCB11 HELLS	8.42e-05	75	135	5	ctd:D019826
Drug	mitragynine	OPRD1 OPRK1 ABCB1	8.80e-05	15	135	3	ctd:C001801
Drug	TRK 820	OPRD1 OPRK1	1.04e-04	3	135	2	ctd:C111212
Drug	Oxycodone	OPRD1 OPRK1	1.04e-04	3	135	2	DB00497
Drug	Hydromorphone	OPRD1 OPRK1	1.04e-04	3	135	2	DB00327
Drug	Codeine	OPRD1 OPRK1	1.04e-04	3	135	2	DB00318
Drug	Carfentanil	OPRD1 OPRK1	1.04e-04	3	135	2	DB01535
Drug	Morphine	OPRD1 OPRK1	1.04e-04	3	135	2	DB00295
Drug	Hydrocodone	OPRD1 OPRK1	1.04e-04	3	135	2	ctd:D006853
Drug	3-Methylfentanyl	OPRD1 OPRK1	1.04e-04	3	135	2	DB01571
Drug	Heroin	OPRD1 OPRK1	1.04e-04	3	135	2	DB01452
Drug	3-Methylthiofentanyl	OPRD1 OPRK1	1.04e-04	3	135	2	DB01439
Drug	morphine-7,8-oxide	OPRD1 OPRK1	1.04e-04	3	135	2	CID005491901
Drug	Levorphanol	OPRD1 OPRK1	1.04e-04	3	135	2	ctd:D007981
Drug	Levallorphan	OPRD1 OPRK1	1.04e-04	3	135	2	ctd:D007977
Drug	NSC11411	OPRD1 OPRK1	1.04e-04	3	135	2	CID000408117
Drug	NSC652297	ABCB1 SLC5A8	1.04e-04	3	135	2	CID000092781
Drug	Buprenorphine	OPRD1 OPRK1	1.04e-04	3	135	2	DB00921
Drug	Levorphanol	OPRD1 OPRK1	1.04e-04	3	135	2	DB00854
Drug	Remifentanil	OPRD1 OPRK1	1.04e-04	3	135	2	DB00899
Drug	Nalbuphine	OPRD1 OPRK1	1.04e-04	3	135	2	DB00844
Drug	Fentanyl	OPRD1 OPRK1	1.04e-04	3	135	2	DB00813
Drug	efonidipine	ABCA1 ABCB1	1.04e-04	3	135	2	ctd:C066425
Drug	Sufentanil	OPRD1 OPRK1	1.04e-04	3	135	2	DB00708
Drug	Ro 64-6198	OPRD1 OPRK1	1.04e-04	3	135	2	CID009844019
Drug	Propoxyphene	OPRD1 OPRK1	1.04e-04	3	135	2	DB00647
Drug	Butorphanol	OPRD1 OPRK1	1.04e-04	3	135	2	DB00611
Drug	Butorphanol	OPRD1 OPRK1	1.04e-04	3	135	2	ctd:D002077
Drug	cyclorphan	OPRD1 OPRK1	1.04e-04	3	135	2	ctd:C084603
Drug	up hit	OPRD1 OPRK1	1.04e-04	3	135	2	CID000129713
Drug	Elacridar	ABCB1 ABCB11	1.04e-04	3	135	2	ctd:C083501
Drug	Alvimopan	OPRD1 OPRK1	1.04e-04	3	135	2	DB06274
Drug	dextrallorphan	OPRD1 OPRK1	1.04e-04	3	135	2	ctd:C044130
Drug	14-phenylpropoxymetopon	OPRD1 OPRK1	1.04e-04	3	135	2	ctd:C478565
Drug	NSC612112	OPRD1 OPRK1	1.04e-04	3	135	2	CID000356432
Drug	indolin-3-one	OPRD1 OPRK1	1.04e-04	3	135	2	CID000230915
Drug	naloxazine	OPRD1 OPRK1	1.04e-04	3	135	2	CID003081567
Drug	3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester	ABCB1 ABCB11	1.04e-04	3	135	2	ctd:C541506
Drug	Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; HL60; HT_HG-U133A	PLA2G7 CHRNA6 ABCA2 RTEL1 SUN1 KCNS1 PRKCQ	1.05e-04	181	135	7	2930_UP
Drug	chalepin	OPRD1 OPRK1 MTX1	1.08e-04	16	135	3	CID000119066
Drug	leflunomide	ADAMTS1 VWA8 ENPP2 ANXA7 SLC19A2 IDH1 ABCA8 ATP6V1H SPPL2A PER2 PTPRG C5 IL1RAP TSSK4 HAO2	1.19e-04	827	135	15	ctd:C045463
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; HL60; HT_HG-U133A	PIEZO1 BHLHE40 MPHOSPH9 DDHD2 IL1RAP NUP160 CDK2	1.20e-04	185	135	7	2927_DN
Drug	Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	COL4A2 DOK5 SZT2 RTEL1 CYP27A1 CPS1 BHLHE40	1.29e-04	187	135	7	5438_UP
Drug	1,2,5,6-dibenzanthracene	ZDHHC2 COL4A2 ABCA1 SLC19A2 TMTC2 DYSF GPR162 BHLHE40 LEPR ABCB1 FRRS1 PER2 PTPRG C5 LTB4R	1.36e-04	837	135	15	ctd:C026486
Drug	sodium	CHRNA6 SLC29A3 ADAMTS1 ENPP2 SLC19A2 IDH1 OPRD1 ATP6V1H PTPRG GUCY2C PYCARD SLC17A7 ABCB11 PRKCQ SLC5A8 SLC17A6	1.53e-04	944	135	16	CID000000923
Drug	Fluorometholone [426-13-1]; Up 200; 10.6uM; HL60; HT_HG-U133A	DOK5 SIGLEC8 CYP27A1 NLGN1 ABCB1 PRKCQ ALK	1.57e-04	193	135	7	2509_UP
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	COL4A3 SZT2 RTEL1 HHAT KCNS1 LTB4R ALK	1.67e-04	195	135	7	5115_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; PC3; HT_HG-U133A	ABCA1 SZT2 DNAH7 SMG7 KCNS1 HAO2 ALK	1.72e-04	196	135	7	3743_DN
Drug	Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A	VWA8 RTEL1 DICER1 MAST4 SLC17A7 KCNS1 MPHOSPH9	1.72e-04	196	135	7	4409_DN
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	SZT2 SUN1 CPS1 GPR162 HOXC4 TRANK1 PRKCQ	1.78e-04	197	135	7	2328_UP
Drug	D-cycloserine [68-41-7]; Up 200; 39.2uM; MCF7; HT_HG-U133A	CHRNA6 SZT2 CYP27A1 DYSF SLC17A7 CDA LTB4R	1.78e-04	197	135	7	3562_UP
Drug	monomethyl phthalate	ABCA1 PDGFRB EZH2 DICER1 OPRK1 ATP6V1H PER2 CADPS BTK ABCB11 CDA PRKCQ SLC5A8 MTX1 ALK CDK2	1.78e-04	957	135	16	ctd:C517284
Drug	Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A	COL4A2 ABCA1 SUN1 BHLHE40 DNAH7 KCNS1 CDK2	1.83e-04	198	135	7	3680_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; HL60; HG-U133A	ABCA2 EZH2 HOXC4 KCNS1 MPHOSPH9 IL1RAP NUP160	1.83e-04	198	135	7	2002_UP
Drug	Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A	SZT2 CYP27A1 DYSF DNAH7 DICER1 KCNS1 LTB4R	1.83e-04	198	135	7	2228_UP
Drug	Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; HL60; HT_HG-U133A	DOK5 CHRNA6 ABCA2 RTEL1 CYP27A1 SYNPO SLC17A7	1.83e-04	198	135	7	2727_UP
Drug	Niridazole [61-57-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A	COL4A2 SIGLEC8 ENPP2 CYP27A1 DYSF DICER1 ALK	1.83e-04	198	135	7	5682_UP
Drug	radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; HL60; HT_HG-U133A	COL4A2 RTEL1 SIGLEC8 DICER1 LEPR HOXC4 SLC17A7	1.83e-04	198	135	7	6178_UP
Drug	Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A	CHRNA6 BHLHE40 LEPR HOXC4 SMG7 PER2 KCNS1	1.83e-04	198	135	7	3900_DN
Drug	Danmme	OPRD1 OPRK1 ABCB1	1.84e-04	19	135	3	CID005486529
Drug	Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A	DOK5 ENPP2 HOXC4 HHAT CARF LTB4R ALK	1.89e-04	199	135	7	3228_UP
Drug	Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A	NPHS1 COL4A3 SZT2 PDGFRB CPS1 FRY TRANK1	1.89e-04	199	135	7	3606_UP
Drug	17-isoprogesterone	BRIX1 COL4A3 CHRNA6 ABCA2 ADAMTS1 PDGFRB ANXA7 CYP27A1 IDH1 EZH2 BHLHE40 ABCB1 CCN6 GUCY2C TBC1D1 PYCARD PRKCQ HSD17B3	1.94e-04	1170	135	18	CID000004920
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	COL4A3 SYNPO CPS1 MAST4 PER2 LTB4R IL1RAP	1.95e-04	200	135	7	5626_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	ABCA2 DYSF DICER1 SCN1A HHAT SLC17A7 ALK	1.95e-04	200	135	7	5570_UP
Drug	Dynorphins	OPRD1 OPRK1	2.08e-04	4	135	2	ctd:D004399
Drug	AC1L5BQM	OPRD1 OPRK1	2.08e-04	4	135	2	CID000174892
Drug	Diprenorphine	OPRD1 OPRK1	2.08e-04	4	135	2	DB01548
Drug	3B-b	OPRD1 OPRK1	2.08e-04	4	135	2	CID000533975
Drug	taxinine K	ABCB1 BTK	2.08e-04	4	135	2	CID005321708
Drug	picenadol	OPRD1 OPRK1	2.08e-04	4	135	2	CID000053076
Drug	sulforhodamine B acid chloride	OPRD1 OPRK1	2.08e-04	4	135	2	CID000065223
Drug	2-methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide	ABCB1 ABCB11	2.08e-04	4	135	2	ctd:C521104
Disease	Liver Cirrhosis, Experimental	ZDHHC2 COL4A2 PDGFRB ENPP2 SLC19A2 CPS1 DYSF ABLIM3 ABCB1 FRY PYCARD HAO2 HELLS	5.41e-05	774	134	13	C0023893
Disease	Hypotension, Orthostatic	OPRD1 ABCB1	6.12e-05	3	134	2	C0020651
Disease	Bipolar Disorder	DOK5 CHRNA6 NLGN1 BHLHE40 TRANK1 PER2 SLC17A7 NRG3 DNAH8 SLC17A6	6.78e-05	477	134	10	C0005586
Disease	Colorectal Carcinoma	ZDHHC2 DNAH3 ABCA1 IDH1 ABCA9 ABCA8 ABCB1 GUCY2C PYCARD PCDH11X ABCB11 DNAH8	8.98e-05	702	134	12	C0009402
Disease	Diffuse Large B-Cell Lymphoma	EZH2 ABCB1 ALK CDK2	1.16e-04	55	134	4	C0079744
Disease	retinal vasculature measurement	COL4A2 PDGFRB STRBP TMTC2 CPS1 DYSF FRY EYS EDEM2 DNAH5	1.31e-04	517	134	10	EFO_0010554
Disease	comparative body size at age 10, self-reported	SEC16B LRRC37A2 LEPR OPRK1 MAST4 CADPS RPTOR TNRC6A ALK	1.34e-04	420	134	9	EFO_0009819
Disease	Withdrawal Symptoms	CHRNA6 OPRD1 OPRK1 PER2	1.43e-04	58	134	4	C0087169
Disease	Drug Withdrawal Symptoms	CHRNA6 OPRD1 OPRK1 PER2	1.43e-04	58	134	4	C0086189
Disease	Substance Withdrawal Syndrome	CHRNA6 OPRD1 OPRK1 PER2	1.43e-04	58	134	4	C0038587
Disease	glioblastoma (is_implicated_in)	PDGFRB IDH1 EZH2	1.73e-04	24	134	3	DOID:3068 (is_implicated_in)
Disease	Albuminuria	NPHS1 LEPR PYCARD	1.73e-04	24	134	3	C0001925
Disease	systemic mastocytosis	ABCA1 ABCA2 EYS	1.96e-04	25	134	3	MONDO_0016586
Disease	Schizophrenia	ABCA1 PDGFRB NLGN1 BHLHE40 DICER1 ABCB1 HHAT EDEM2 SLC17A7 NRG3 TNXB ALK SLC17A6	2.00e-04	883	134	13	C0036341
Disease	Granulosa Cell Cancer	DICER1 LEPR	2.03e-04	5	134	2	C1567257
Disease	internal carotid intimal medial thickness	MAST4 NRG3	2.03e-04	5	134	2	EFO_0005053
Disease	Adult Diffuse Large B-Cell Lymphoma	EZH2 CDK2	2.03e-04	5	134	2	C1332201
Disease	white matter integrity, age at assessment	COL4A2 OR2B3 CARF	2.21e-04	26	134	3	EFO_0004641, EFO_0008007
Disease	blood nickel measurement	ZDHHC2 OPRK1 EYS RPTOR USH2A	2.25e-04	120	134	5	EFO_0007583
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	SEC16B NLGN1 HOXC4 PTPRG RPTOR TNRC6A SKOR1 ACMSD	2.69e-04	364	134	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	amino acid measurement	SYNPO NLGN1 CPS1 GPR162 DNAH7 PTPRG GUCY2C HHAT C5 NRG3 ALK	2.78e-04	678	134	11	EFO_0005134
Disease	Colorectal Neoplasms	ABCA1 ABCA9 ABCA8 ABCB1 GUCY2C PYCARD ABCB11	2.84e-04	277	134	7	C0009404
Disease	Leukemia, Myelomonocytic, Chronic	PDGFRB EZH2	3.03e-04	6	134	2	C0023480
Disease	choline measurement	ABCA1 CPS1 LEPR ABCB11 HSD17B3	3.26e-04	130	134	5	EFO_0010116
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	NPHS1 COL4A3 NUP160	3.40e-04	30	134	3	C1868672
Disease	pentachlorophenol measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022071
Disease	parathion measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022070
Disease	potassium chromate measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022072
Disease	mercuric chloride measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022068
Disease	heptachlor epoxide measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022067
Disease	methoxychlor measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022052
Disease	azinphos methyl measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022055
Disease	aldrin measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022054
Disease	dicofol measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022060
Disease	disulfoton measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022062
Disease	dieldrin measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022061
Disease	endrin measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022064
Disease	endosulfan measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022063
Disease	heptachlor measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022066
Disease	ethion measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022065
Disease	chlorpyrifos measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022057
Disease	cadmium chloride measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022056
Disease	diazinon measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022059
Disease	dibutyl phthalate measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0022058
Disease	environmental exposure measurement	OPRK1 EYS RPTOR USH2A	3.47e-04	73	134	4	EFO_0008360
Disease	coronary artery disease	COL4A2 ABCA1 DOCK8 TUB ABCA8 MAST4 RPTOR HHAT CARF EDEM2 C5 TNXB RHOF ALK NUP160	3.55e-04	1194	134	15	EFO_0001645
Disease	DDT metabolite measurement	OPRK1 EYS RPTOR USH2A	3.66e-04	74	134	4	EFO_0007886
Disease	body fat percentage	SEC16B DMXL2 NLGN1 HOXC4 PTPRG RPTOR TNRC6A SKOR1 ACMSD	4.05e-04	488	134	9	EFO_0007800
Disease	B-cell lymphoma (is_implicated_in)	EZH2 BTK	4.24e-04	7	134	2	DOID:707 (is_implicated_in)
Disease	colorectal adenocarcinoma (is_implicated_in)	EZH2 ABCB1 FAM151A	5.39e-04	35	134	3	DOID:0050861 (is_implicated_in)
Disease	Early Childhood Epilepsy, Myoclonic	SCN1A TNRC6A	5.63e-04	8	134	2	C0393695
Disease	Idiopathic Myoclonic Epilepsy	SCN1A TNRC6A	5.63e-04	8	134	2	C0338478
Disease	Symptomatic Myoclonic Epilepsy	SCN1A TNRC6A	5.63e-04	8	134	2	C0338479
Disease	Benign Infantile Myoclonic Epilepsy	SCN1A TNRC6A	5.63e-04	8	134	2	C0751120
Disease	Myoclonic Encephalopathy	SCN1A TNRC6A	5.63e-04	8	134	2	C0438414
Disease	diffuse large B-cell lymphoma (is_marker_for)	EZH2 DICER1	5.63e-04	8	134	2	DOID:0050745 (is_marker_for)
Disease	Myoclonic Absence Epilepsy	SCN1A TNRC6A	5.63e-04	8	134	2	C0393703
Disease	cystic fibrosis (implicated_via_orthology)	ABCB1 ABCB11	7.22e-04	9	134	2	DOID:1485 (implicated_via_orthology)
Disease	Myoclonic Epilepsy	SCN1A TNRC6A	7.22e-04	9	134	2	C0014550
Disease	ceramide measurement	SEC16B ABCA1 NLGN1 CPS1 EYS PRKCQ	7.36e-04	235	134	6	EFO_0010222
Disease	alkaline phosphatase measurement	NBPF3 COL4A2 SEC16B ZNF318 CPS1 BHLHE40 LEPR MED24 TRANK1 EDEM2 ABCB11 CDA NUP160	7.45e-04	1015	134	13	EFO_0004533
Disease	Epilepsy, Myoclonic, Infantile	SCN1A TNRC6A	8.99e-04	10	134	2	C0917800
Disease	cerebrospinal fluid biomarker measurement	PLA2G7 PDGFRB LEPR ATP6V1H	9.78e-04	96	134	4	EFO_0006794
Disease	cocaine use	CHRNA6 SCN1A	1.10e-03	11	134	2	C3496069
Disease	Hyperhomocysteinemia	NPHS1 PYCARD	1.10e-03	11	134	2	C0598608
Disease	Myoclonic Astatic Epilepsy	SCN1A TNRC6A	1.10e-03	11	134	2	C0393702
Disease	Mental Depression	CHRNA6 SLC29A3 OPRK1 ABCB1 PER2 ALK	1.10e-03	254	134	6	C0011570
Disease	fibrinogen measurement, tissue plasminogen activator measurement	CPS1 LEPR SPPL2A	1.13e-03	45	134	3	EFO_0004623, EFO_0004791
Disease	fibrinogen measurement, plasminogen activator inhibitor 1 measurement	CPS1 LEPR SPPL2A	1.13e-03	45	134	3	EFO_0004623, EFO_0004792
Disease	blood cobalt measurement	OPRK1 EYS RPTOR USH2A	1.18e-03	101	134	4	EFO_0007577
Disease	Weight Gain	ZDHHC2 EZH2 LEPR PYCARD	1.23e-03	102	134	4	C0043094
Disease	Malignant neoplasm of breast	ADAMTS1 STRBP LRRC37A2 ZNF318 EZH2 DYSF LEPR ABCB1 PER2 BTK CDA ALK SLC17A6	1.24e-03	1074	134	13	C0006142
Disease	Neuroblastoma	DOCK8 ABCB1 ALK	1.28e-03	47	134	3	C0027819
Disease	Hematologic Neoplasms	IDH1 ABCB1	1.31e-03	12	134	2	C0376545
Disease	Agammaglobulinemia	CD19 BTK	1.31e-03	12	134	2	C0001768
Disease	ocular hypertension, response to triamcinolone acetonide	VWA8 LIPK FRRS1	1.45e-03	49	134	3	EFO_0006954, EFO_1001069
Disease	Infantile Severe Myoclonic Epilepsy	SCN1A TNRC6A	1.55e-03	13	134	2	C0751122
Disease	free androgen index	COL4A2 ZNF318 CPS1 ABCA8 LEPR PTPRG NUP160	1.65e-03	374	134	7	EFO_0007005
Disease	Squamous cell carcinoma of the head and neck	ABCB1 IL1RAP CDK2	1.72e-03	52	134	3	C1168401
Disease	membranous glomerulonephritis (biomarker_via_orthology)	NPHS1 ABCA1	1.80e-03	14	134	2	DOID:10976 (biomarker_via_orthology)
Disease	serum urea measurement	COL4A2 CYP27A1 ZNF318 CPS1 SPPL2A	2.01e-03	195	134	5	EFO_0009795
Disease	Ischemic stroke, fibrinogen measurement	CPS1 LEPR SPPL2A	2.02e-03	55	134	3	EFO_0004623, HP_0002140
Disease	Hypogonadotropic hypogonadism	SLC29A3 LEPR	2.07e-03	15	134	2	C0271623
Disease	Rhabdomyosarcoma	DICER1 ALK	2.07e-03	15	134	2	C0035412
Disease	Primary hypogonadism	SLC29A3 LEPR	2.07e-03	15	134	2	C0948896
Disease	Hypogonadism, Isolated Hypogonadotropic	SLC29A3 LEPR	2.07e-03	15	134	2	C3489396
Disease	Depressive disorder	CHRNA6 SLC29A3 OPRK1 ABCB1 PER2 ALK	2.11e-03	289	134	6	C0011581
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	CPS1 LEPR SPPL2A	2.13e-03	56	134	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	Liver carcinoma	ZDHHC2 ADAMTS1 IDH1 EZH2 ABCB1 PYCARD IL1RAP HAO2	2.27e-03	507	134	8	C2239176
Disease	fibrinogen measurement, factor VII measurement	CPS1 LEPR SPPL2A	2.35e-03	58	134	3	EFO_0004619, EFO_0004623
Disease	atherosclerosis (is_implicated_in)	COL4A2 PLA2G7	2.36e-03	16	134	2	DOID:1936 (is_implicated_in)
Disease	Hypogonadism	SLC29A3 LEPR	2.36e-03	16	134	2	C0020619
Disease	mean platelet volume	CFAP251 DOCK8 CPS1 LEPR OPRD1 FRY TRANK1 MAST4 TNRC6A MAP3K11 KCNS1 RHOF	2.42e-03	1020	134	12	EFO_0004584
Disease	diffuse plaque measurement	VWA8 DOCK8 ABLIM3 ABCA8 EYS MAST4 PTPRG CADPS NRG3 SLC17A6	2.47e-03	758	134	10	EFO_0010699
Disease	Inborn Errors of Metabolism	PLA2G7 LEPR	2.66e-03	17	134	2	C0025521
Disease	partial epilepsy	TBC1D32 SCN1A	2.66e-03	17	134	2	EFO_0004263
Disease	Antibody Deficiency Syndrome	LEPR C5	2.66e-03	17	134	2	C0003257
Disease	extrahepatic cholestasis (biomarker_via_orthology)	ABCA1 CYP27A1	2.66e-03	17	134	2	DOID:13619 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PPIMNYMISYSWTKN	PTPRG	376	P23470
PSKMRKLFSFTPAWN	PYCARD	156	Q9ULZ3
MKARSSSYADPWTPP	ABLIM3	531	O94929
SSQYSSFLFWRMPIP	MLLT11	6	Q13015
RNDYSYWLSTPALMP	COL4A3	1516	Q01955
LEKSDNPYPWPMFSS	TBC1D32	891	Q96NH3
VRWSPPEVLMYSKFS	BTK	561	Q06187
TFFWIPMAASFTPYI	ABCA9	1026	Q8IUA7
SATAYLPMLEKCWYP	BHLHE40	331	O14503
NLVFTPAWFSPIMYK	FBXO10	181	Q9UK96
PAWFSPIMYKTTSGH	FBXO10	186	Q9UK96
GWSITPLMYPASFVF	ABCA1	1746	O95477
NDKSYWLSTTAPLPM	COL4A2	1561	P08572
KFSAPEWPYMLVGSV	ABCB11	746	O95342
QALSTVPVMFSYWAK	ACMSD	71	Q8TDX5
LYMWLSNSPHGPSAK	BRIX1	126	Q8TDN6
ILALFMPPTYYDAWS	ANXA7	251	P20073
MWDYFVAKPFLPLSD	DMXL2	2456	Q8TDJ6
PFSTTDSAYEWKMPK	DICER1	1471	Q9UPY3
VMKFRPLTWQTSHPY	BMS1	241	Q14692
FFGIYSSLWPAIPMA	ATP8A1	1021	Q9Y2Q0
DKSTPVYPLTMTWSF	CFAP251	241	Q8TBY9
YWVMNAPTVAAPTKL	RGS11	281	O94810
QPWSPCSAYMITSFL	ADAMTS1	441	Q9UHI8
VNKTYPVDMSPTFTW	GUCY2C	401	P25092
KPTVSVFSMFRYSNW	ABCB1	31	P08183
MPSWPTAAYATSSYL	NRG3	221	P56975
QMPTFSAPSWMAAIY	CADPS	1041	Q9ULU8
NPEPSLMWYKDSRTV	NPHS1	471	O60500
WTDPKLNSPMYFFLG	OR10AD1	51	Q8NGE0
IYMYLQPPSSTSKDW	OR2B3	256	O76000
STLPNWMAEFKRFTP	HELLS	281	Q9NRZ9
IQKKPTMYPPWDSTF	PRKCQ	46	Q04759
KLSSIIPSAFPSWYM	MAGEC3	591	Q8TD91
IPSAFPSWYMDALKD	MAGEC3	596	Q8TD91
TSSSMSVIRPDWPYF	EYS	1806	Q5T1H1
QPLWFKDMYKPLSAT	LRRC37A2	1646	A6NM11
VSFFSLKSDSAPPWM	GPR162	291	Q16538
MKFYAVVATSPASWE	MYO19	146	Q96H55
YFPSSVKPTITWYMG	IL1RAP	166	Q9NPH3
PATRLMWKSQYVPYD	CARF	256	Q8N187
TVSMPVFQSLEAYWP	EDEM2	306	Q9BV94
LNAVASVPIMYSWSP	EZH2	101	Q15910
SFTSPYKLPLWSMCS	PER2	241	O15055
SNLPMWKPMLYTVAF	DNAH8	4041	Q96JB1
MAWKSFTRAPYPALQ	DDHD2	596	O94830
AFYLSKPDETPNAWM	MPHOSPH9	191	Q99550
WRFKLSCMPPNSTYD	LEPR	31	P48357
SLSTMVPLPRSAYWQ	DOK5	256	Q9P104
LWLTMENPGYSLPSK	KCNS1	206	Q96KK3
SSWAVSFQPAKYARM	NLGN1	341	Q8N2Q7
MGKYNWVTTPTTFKP	PCDH11X	916	Q9BZA7
WKTNMSLCFPRYPSE	LTB4R	161	Q15722
PFDWQYINPVAHMKS	PLA2G7	21	Q13093
TLPFQSAKYLMETWP	OPRD1	101	P41143
QLPAASTSYSFPWML	HHAT	191	Q5VTY9
WTLSIPPDMSASYQS	NBPF3	351	Q9H094
SYKTMPAYRNLPLIW	CCN6	191	O95389
KYNGMITWTPPAIFK	CHRNA6	141	Q15825
IPADYVAIKAPMFSW	CPS1	1301	P31327
SFQMALSKGWPLYLS	IDH1	196	O75874
SPKAFMADQQLPYWV	KDM1B	126	Q8NB78
KYRMPFAWAPISLSS	DOCK8	396	Q8NF50
FYPPLMQRTSWTLAA	DNAH3	81	Q8TD57
GKVPAMWAAKSYPSL	DNAH3	3921	Q8TD57
SPSGKLMSPKLYVWA	CD19	146	P15391
YPKATLSPGWTTFYM	FAM151A	201	Q8WW52
PDPAFTYEWTKVASM	C19orf44	536	Q9H6X5
LNLPDSWKTYAMTGF	FRRS1	506	Q6ZNA5
PSNPRYGMWTIKAKY	C5	191	P01031
LMFQNSLYATFLPKW	CYP27A1	246	Q02318
FRMWLTSYPSPNFPV	DNAH7	3516	Q8WXX0
SSAASKQPIVYPWMK	HOXC4	126	P09017
LYGWSITPIMYPASF	ABCA2	1881	Q9BZC7
PSSLKMNKSYLLEPW	MAST4	1861	O15021
AWPYAFTRLQSVMPL	FRY	876	Q5TBA9
TSMPDYKPSFPKWAR	CDK2	231	P24941
SKPVYVINWFMSFGP	FAM104B	86	Q5XKR9
GIALFPWPLYSMYSA	HSD17B3	186	P37058
PWPLYSMYSASKAFV	HSD17B3	191	P37058
AFAVAWFLPMPQKSL	SLC19A2	201	O60779
PDTSFLWFTSPYKTM	DYSF	2021	O75923
SSGISWMLFNLAKYP	CYP4F22	341	Q6NT55
FLMPLWTSYTVSKQA	ENPP2	626	Q13822
YAWMAPEVIKASTFS	MAP3K11	286	Q16584
SSGSQWKPMLYAVAF	DNAH5	4176	Q8TE73
MASYLLPGQKSPWFF	FAM120B	301	Q96EK7
NYISKGSTFLPLKWM	PDGFRB	856	P09619
PLKWMAPESIFNSLY	PDGFRB	866	P09619
TMPFQSTVYLMNSWP	OPRK1	111	P41145
IWYSSSALSPMLANF	OR13F1	71	Q8NGS4
VTRKWYAEAMPFPLN	MTX1	271	Q13505
PSYPVMEKSLEFWRA	RTEL1	561	Q9NZ71
SPSSAWMEPRYKEAA	SZT2	1276	Q5T011
EYWMFKLRNSSSPAT	SLC29A3	76	Q9BZD2
AATVYPTFPMFWPAA	SKOR1	481	P84550
VHFMKNYNPSAIWEP	USH2A	1676	O75445
MNPTSYDNVLIKWFP	RHOF	101	Q9HBH0
RCSKNTAWPYFLPML	ATP6V1H	116	Q9UI12
GWYKLFPTSSMVDPA	RIMS4	231	Q9H426
YPPAANELTMRKSWI	FILIP1	856	Q7Z7B0
TMSLPSSWKYPTNAP	SYNPO	756	Q8N3V7
IPYFQMTPISTSLCW	HAO2	191	Q9NYQ3
MPESLLASSPAWKQF	SPATA31A7	881	Q8IWB4
YNAYPLPAVKVSMDW	SMG7	356	Q92540
LAKQFWISASMYPPS	HOATZ	36	Q6PI97
WISASMYPPSESQLV	HOATZ	41	Q6PI97
KFPSTGVDTMPYWNL	MED24	686	O75448
PRPWLSSSFPAYMSK	TMEM69	46	Q5SWH9
LDVSYPPWNLTMTVF	SIGLEC8	241	Q9NYZ4
WTAKKVSAPDQLMPY	SLC5A8	311	Q8N695
LPSSKPFQKYSWSVT	STRBP	331	Q96SI9
SAKLMNPLTKFSTPW	SLC17A7	281	Q9P2U7
FSYEGSWTQKPTSML	PMIS2	91	A0A1W2PS18
SATAPMVWLPYSSID	NUP160	1376	Q12769
DWSARYFAQPVMKIP	RPTOR	961	Q8N122
TMSNPPDWTKNVEYT	SCN1A	146	P35498
KQFVWYTPPTFMIAV	STEAP1	281	Q9UHE8
MFWLVLTSSCPPYIA	ABCA8	1026	O94911
TNMPSPSPDYFTWNL	ALK	231	Q9UM73
TNWPVYMTKPDGTYI	CDA	111	P32320
MPESLLASSPAWKQF	SPATA31A3	881	Q5VYP0
TPWRKFFTSMPVYAI	SLC17A6	301	Q9P2U8
TYMRPSPDFSKIAWF	TDP1	496	Q9NUW8
RGLPYNPFLSDTWSM	TSSK4	211	Q6SA08
VFTLWYNLLPSKQMP	WWC2	816	Q6AWC2
MPESLLASSPAWKQF	SPATA31A1	881	Q5TZJ5
MPESLLASSPAWKQF	SPATA31A5	881	Q5VU36
ARLYWMGNKPPSFSN	TMTC2	241	Q8N394
ITVKMYSPSWPNFDY	SPPL2A	156	Q8TCT8
WMPPPSRADSFKVSY	TNXB	3776	P22105
GPSLYAAPWFLTMFA	TBC1D1	961	Q86TI0
AAPWFLTMFASQFPL	TBC1D1	966	Q86TI0
PVNSKDLQHIWPFMY	UBE2O	186	Q9C0C9
YQPTPWEAASDSMKR	MRPL18	146	Q9H0U6
KALPPMRGFKYTSWS	GTF3C4	156	Q9UKN8
LFLSSKMDPQTYSWV	SEC16B	471	Q96JE7
WKTIFTLPMNPSKEF	ZDHHC2	71	Q9UIJ5
PMNSALIKWLYLPDF	PIEZO1	1076	Q92508
MSLFGIPLWYFSQSP	SUN1	641	O94901
WLSAMQAFLLSSNYP	TRANK1	2286	O15050
LMSPSEVYSWKRPSS	VWA8	1376	A3KMH1
MTSKPHSDWIPYSVL	TUB	1	P50607
AYAASRWPMYPTSQP	ZNF318	796	Q5VUA4
NSSLNWPPYTKKMSS	TNRC6A	1161	Q8NDV7
SPKSPEYWAFSLDEM	LIPK	131	Q5VXJ0
MLWKAPVYSGSSPVS	MYOM2	831	P54296